Epigenetic Mechanisms of Resistance to Immune Checkpoint Inhibitors

Immune checkpoint inhibitors (ICIs) have demonstrated to be highly efficient in treating solid tumors; however, many patients have limited benefits in terms of response and survival. This rapidly led to the investigation of combination therapies to enhance response rates. Moreover, predictive biomar...

Descripción completa

Detalles Bibliográficos
Autores principales: Perrier, Alexandre, Didelot, Audrey, Laurent-Puig, Pierre, Blons, Hélène, Garinet, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407667/
https://www.ncbi.nlm.nih.gov/pubmed/32708698
http://dx.doi.org/10.3390/biom10071061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407667/
https://www.ncbi.nlm.nih.gov/pubmed/32708698
http://dx.doi.org/10.3390/biom10071061

Ejemplares similares